Table 2.
Before and after values for covariates of study patientsa
| Parameter | Sarpogrelate
|
Aspirin
|
||||
|---|---|---|---|---|---|---|
| Before | After | P | Before | After | P | |
| BMI (kg/m2) | 24.10 ± 0.56 | 24.00 ± 0.63 | NS | 23.70 ± 0.69 | 23.80 ± 0.66 | NS |
| HbA1c (%) | 6.70 ± 0.11 | 6.60 ± 0.14 | NS | 6.60 ± 0.09 | 6.70 ± 0.10 | NS |
| SBP (mmHg) | 135.00 ± 5.52 | 134.00 ± 5.75 | NS | 139.00 ± 7.32 | 137.00 ± 7.01 | NS |
| DBP (mmHg) | 71.50 ± 2.76 | 71.20 ± 2.85 | NS | 75.40 ± 2.87 | 73.30 ± 3.55 | NS |
| Cr (mg/dl) | 0.76 ± 0.05 | 0.77 ± 0.08 | NS | 0.75 ± 0.06 | 0.76 ± 0.05 | NS |
| eGFR (ml/min) | 72.40 ± 6.13 | 71.90 ± 6.67 | NS | 73.50 ± 6.54 | 72.80 ± 7.13 | NS |
| TC (mg/dl) | 194.00 ± 8.77 | 192.00 ± 9.04 | NS | 188.00 ± 7.85 | 190.00 ± 9.37 | NS |
| TG (mg/dl) | 113.00 ± 11.22 | 124.00 ± 15.62 | NS | 104.00 ± 11.03 | 110.00 ± 13.89 | NS |
| HDL cholesterol (mg/dl) | 47.60 ± 2.37 | 46.40 ± 2.49 | NS | 46.20 ± 2.10 | 47.70 ± 2.50 | NS |
| ANP (pg/ml) | 36.10 ± 5.61 | 38.60 ± 6.32 | NS | 38.40 ± 4.34 | 39.50 ± 6.62 | NS |
| BNP (pg/ml) | 55.90 ± 4.83 | 58.20 ± 5.21 | NS | 49.40 ± 4.29 | 52.20 ± 5.33 | NS |
| hsCRP (mg/dl) | 0.154 ± 0.04 | 0.158 ± 0.04 | NS | 0.146 ± 0.03 | 0.143 ± 0.03 | NS |
Data are means ± SEM. ANP, atrial natriuretic peptide; BMI, body mass index; BNP, brain natriuretic peptide; Cr, serum creatinine; DBP, diastolic BP; eGFR, estimated GFR; HbA1c, glycosylated hemoglobin; hsCRP, high-sensitivity C-reactive protein; SBP, systolic BP; TC, serum total cholesterol; TG, serum triglyceride.